About this trial
The goal of this clinical trial is to evaluate gingival recession depth reduction using tunneled coronally advanced flap compared to coronally advanced flap, both combined with connective tissue graft in patients with isolated RT2 gingival recession sites.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Patients age 18 years or older.
Isolated recession defect classified as RT2.
Patients with healthy systemic condition.
Clinical indication and/or patient request for root coverage.
Disqualifiers
Pregnant females
Smokers: a contraindication for any plastic periodontal surgery.
Unmotivated and uncooperative patients with poor oral hygiene
Patients with habits that may compromise the longevity and affect the result of the study as alcoholism or parafunctional habits.
Trial design
Parallel
Treatments tested in this trial
Tunneled coronal advanced flap with connective tissue graft
Procedure/SurgeryTunneled coronal advanced flap with connective tissue graft to treat isolated RT2 gingival recession sites.
Coronally advanced flap with connective tissue graft
Procedure/SurgeryCoronally advanced flap with connective tissue graft to treat isolated RT2 gingival recession sites
Treatment groups
Trial outcomes
Primary outcomes
Gingival Recession Depth
It's measured as the distance between cemento-enamel junction (CEJ), and gingival margin (GM) using periodontal probe.
Secondary outcomes
Percentage of mean root coverage (MRC%)
(Preoperative vertical recession depth - Postoperative vertical recession/preoperative vertical recession) x 100 \[%\]
Percentage of complete root coverage (CRC%)
Number of defect sites with complete root coverage/ Total number of recession sites treated x 100 \[%\]
Gingival Recession Width
Measured at the widest point (it is the distance between the mesial gingival margin and the distal gingival margin of the tooth)
Gingival Thickness
Measured using transgingival needle probing using anesthesic needle a rubber stopper
Sponsors and contacts
Click on the lead sponsor to view all of their trials.